Credit Suisse Ag Zomedica Corp. Transaction History

Credit Suisse Ag

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.2 - $0.34 $107,163 - $182,178	-535,818 Reduced 99.6%	2,151 $0
Q1 2022 May 16, 2022	BUY	$0.28 - $0.4 $11,001 - $15,716	39,290 Added 7.88%	537,969 $182,000
Q4 2021 Feb 14, 2022	SELL	$0.31 - $0.58 $23,321 - $43,633	-75,231 Reduced 13.11%	498,679 $153,000
Q3 2021 Nov 12, 2021	SELL	$0.46 - $0.81 $441 - $776	-959 Reduced 0.17%	573,910 $301,000
Q2 2021 Aug 16, 2021	BUY	$0.72 - $1.46 $404,430 - $820,095	561,709 Added 4268.31%	574,869 $479,000
Q1 2021 May 14, 2021	BUY	$0.35 - $2.7 $4,606 - $35,532	13,160 New	13,160 $20,000

80.9M

Ticker ZOM
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 979,950,016
Market Cap $127M
Description
Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.